CAS: 1021868-76-7
Lorglumide Sodium Salt
CAS:1021868-76-7
Formula:
C22H31Cl2N2NaO4
Purity:
99%
Color and Shape:
Solid
Molecular weight:
481.3883
Ref: IN-DA008S4V
| 5mg | 214.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Ref: 7W-GP2997
| Undefined size | To inquire |
Estimated delivery in United States, on Thursday 12 Dec 2024
Lorglumide sodium salt
CAS:1021868-76-7
Lorglumide sodium salt is a guanine nucleotide-binding protein that has low potency and is used …
Formula:
C22H31Cl2N2NaO4
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
481.39 g/mol
Ref: 3D-FL43268
| 1mg | 138.00 € | ||
| 2mg | 194.00 € | ||
| 5mg | 310.00 € | ||
| 10mg | 436.00 € | ||
| 25mg | 647.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
Lorglumide Sodium Salt
Controlled ProductCAS:1021868-76-7
Stability Hygroscopic Applications Lorglumide Sodium Salt is a nonpeptidic antagonist of the CCK A recepotor, …
Formula:
C22H31Cl2N2NaO4
Color and Shape:
Neat
Molecular weight:
481.39
Ref: TR-L469910
| 50mg | 177.00 € | ||
| 250mg | 527.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Lorglumide sodium salt
CAS:1021868-76-7
Lorglumide sodium salt (CR-1409 sodium salt) is an antagonist of cholecystokinin receptors (CCK).
Formula:
C22H31Cl2N2NaO4
Purity:
99.32%
Color and Shape:
Solid
Molecular weight:
481.39
Ref: TM-T11868
| 5mg | 34.00 € | ||
| 10mg | 50.00 € | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 1mL*10mM (DMSO) | 36.00 € |
Estimated delivery in United States, on Wednesday 29 Jan 2025
